Scientists from Ben-Gurion University of the Negev have made a potentially revolutionary discovery regarding the biological function of an anticancer peptide as a protein kinase inhibitor. The researchers’ discovery, which focused on a naturally occurring peptide from the non-coding region of mRNA, could greatly contribute to how we treat cancer in the future.
Quote s: “Peptides are short chains of amino acids linked by peptide bonds. Long molecules made of peptide units are what we know as proteins, and protein kinases are enzymes that can change a protein’s function.” | “In their research, the scientists were able to isolate and confirm that one of the short peptides acts as a kinase inhibitor, meaning it inhibits the progression of cancer between the stages of cancer cell development through metastasis.”
Source: The Jerusalem Post (introduction and quotations)
Learn more about Ben-Gurion University of the Negev from Wikipedia. ►
Read “Anticancer breakthrough from BGU scientists could change how we treat the disease” ►
Photo: Ben-Gurion University
We welcome your comments. Click here.
To learn about these and many more AmazingJews, watch a compilation put together by JewOfTheWeek.net in 2015 and posted on YouTube.